Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.

TSX:TH - Post by User

Theratechnologies Inc > Delay in Phase 1 a --------Get over it

<< Previous

Bullboard Posts

Next >>

Comment by qwerty22on Mar 29, 2022 7:31am

35 Views

Post# 34554496

RE:RE:RE:RE:RE:RE:RE:RE:RE:Delay in Phase 1 a --------Get over it

I agree. Got to differentiate between JFM's pet projects and the company.

jfm1330 wrote: I can guarantee you that he is not...

SPCEO1 wrote: I am pretty sure Christian is on top of such things way more than any of us, even JFM.